To KK - Search Results

1

Upregulation of ABCG2 by romidepsin via the aryl hydrocarbon receptor pathway.

To KK, Robey R, Zhan Z, Bangiolo L, Bates SE. To KK, et al. Mol Cancer Res. 2011 Apr;9(4):516-27. doi: 10.1158/1541-7786.MCR-10-0270. Epub 2011 Feb 25. Mol Cancer Res. 2011. PMID: 21357443 Free PMC article.

2

Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.

To KK, Zhan Z, Bates SE. To KK, et al. Mol Cell Biol. 2006 Nov;26(22):8572-85. doi: 10.1128/MCB.00650-06. Epub 2006 Sep 5. Mol Cell Biol. 2006. PMID: 16954373 Free PMC article.

3

Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan.

Liao Z, Robey RW, Guirouilh-Barbat J, To KK, Polgar O, Bates SE, Pommier Y. Liao Z, et al. Among authors: to kk. Mol Pharmacol. 2008 Feb;73(2):490-7. doi: 10.1124/mol.107.041178. Epub 2007 Nov 5. Mol Pharmacol. 2008. PMID: 17984197 Free PMC article.

4

Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.

To KK, Polgar O, Huff LM, Morisaki K, Bates SE. To KK, et al. Mol Cancer Res. 2008 Jan;6(1):151-64. doi: 10.1158/1541-7786.MCR-07-0175. Mol Cancer Res. 2008. PMID: 18234970 Free PMC article.

5

Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.

To KK, Zhan Z, Litman T, Bates SE. To KK, et al. Mol Cell Biol. 2008 Sep;28(17):5147-61. doi: 10.1128/MCB.00331-08. Epub 2008 Jun 23. Mol Cell Biol. 2008. PMID: 18573883 Free PMC article.

6

Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2.

To KK, Robey RW, Knutsen T, Zhan Z, Ried T, Bates SE. To KK, et al. Mol Cancer Ther. 2009 Oct;8(10):2959-68. doi: 10.1158/1535-7163.MCT-09-0292. Mol Cancer Ther. 2009. PMID: 19825807 Free PMC article.

7

Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells.

To KK, Yu L, Liu S, Fu J, Cho CH. To KK, et al. Mol Carcinog. 2012 Jun;51(6):449-64. doi: 10.1002/mc.20810. Epub 2011 Jun 15. Mol Carcinog. 2012. PMID: 21678497

8

Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migration.

Ierano C, Basseville A, To KK, Zhan Z, Robey RW, Wilkerson J, Bates SE, Scala S. Ierano C, et al. Among authors: to kk. Cancer Biol Ther. 2013 Feb;14(2):175-83. doi: 10.4161/cbt.22957. Epub 2012 Nov 28. Cancer Biol Ther. 2013. PMID: 23192271 Free PMC article.

9

Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells.

To KK, Ren SX, Wong CC, Cho CH. To KK, et al. Peptides. 2013 Feb;40:13-21. doi: 10.1016/j.peptides.2012.12.019. Epub 2012 Dec 27. Peptides. 2013. PMID: 23274176

10

Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.

To KK, Tomlinson B. To KK, et al. Br J Pharmacol. 2013 Nov;170(5):1137-51. doi: 10.1111/bph.12367. Br J Pharmacol. 2013. PMID: 24032744 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters